Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACBMNC for Treatment of BPD in Extremely Preterm Neonates
NCT05071638Phase 3Unknown
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Oct 2021
- Primary completion
- Mar 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous cord blood mononuclear cells in bronchopulmonary dysplasia (BPD), sponsored by Guangdong Women and Children Hospital. Status: unknown.
02
Drugs
autologous cord blood mononuclear cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT05071638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05071638.